SMTL ID : 4c4g.1

Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

monomer

Ligands

1 x 7RO: tert-butyl 6-((2-chloro-4-(dimethylcarbamoyl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate(Non-covalent)

7RO.1: 20 residues within 4Å: Chain A: I.36, G.37, V.44, Q.46, A.56, K.58, L.80, I.91, M.105, M.107, E.108, C.109, G.110, N.111, I.112, D.113, S.116, L.159, I.168 Ligands: 7PE.2 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.56, A:I.91 Hydrogen bonds: A:G.110, A:G.110 Halogen bonds: A:Q.46

2 x 7PE: 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL(Non-functional Binders)

7PE.2: 8 residues within 4Å: Chain A: S.42, K.58, V.60, Y.73, E.76, M.105, A.173 Ligands: 7RO.1 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.42, A:S.42, A:K.58 7PE.3: 4 residues within 4Å: Chain A: W.127, K.130, S.131, K.134 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:W.127

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 4 residues within 4Å: Chain A: H.141, H.144, I.287, P.288 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:H.141, A:H.144 Water bridges: A:I.287 EDO.5: 3 residues within 4Å: Chain A: K.278, R.279, D.280 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.279, A:R.279, A:D.280

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Naud, S. et al., Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3, 2-C]Pyridine Inhibitors of the Mitotic Kinase Monopolar Spindle 1 (Mps1). J.Med.Chem. (2013)

Release Date

2013-12-04

Peptides

DUAL SPECIFICITY PROTEIN KINASE TTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

DUAL SPECIFICITY PROTEIN KINASE TTK

Related Entries With Identical Sequence